FDA Inspection 1022663 — American Red Cross Blood Services
The FDA completed an inspection of American Red Cross Blood Services on July 14, 2017 in Bangor, ME. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 14, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Bangor, ME (United States)